Intrinsic Value of S&P & Nasdaq Contact Us

Healthpeak Properties, Inc. DOC NYSE

NYSE • Real Estate • REIT - Healthcare Facilities • US • USD

SharesGrow Score
57/100
2/7 Pass
SharesGrow Intrinsic Value
$28.42
+68.4%
Analyst Price Target
$18.00
+6.7%

Healthpeak Properties, Inc. (DOC) is a REIT - Healthcare Facilities company in the Real Estate sector, currently trading at $16.87. It has a SharesGrow Score of 57/100, indicating a above average investment profile with 2 out of 7 criteria passed.

SharesGrow calculates the intrinsic value of DOC = $28.42 (+68.4% from the current price, the stock appears undervalued). Analyst consensus target is DOC = $18 (+6.7% upside).

Valuation: DOC trades at a trailing Price-to-Earnings (P/E) of 161 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 8.11.

Financials: revenue is $2.8B, +114.2%/yr average growth. Net income is $71M, growing at +206.1%/yr. Net profit margin is 2.5% (thin). Gross margin is 22.5% (-45 pp trend).

Balance sheet: total debt is $10.4B against $7.5B equity (Debt-to-Equity (D/E) ratio 1.39, moderate). Current ratio is 1.09 (adequate). Debt-to-assets is 51.3%. Total assets: $20.3B.

Analyst outlook: 22 / 40 analysts rate DOC as buy (55%) — moderate consensus.

SharesGrow 7-Criteria breakdown: Value 42/100 (Partial), Growth 100/100 (Pass), Past 100/100 (Pass), Health 33/100 (Fail), Moat 44/100 (Fail), Future 52/100 (Partial), Income 30/100 (Fail).

$18.00
▲ 6.7% Upside
Average Price Target
Based on 40 Wall Street analysts offering 12-month price targets for Healthpeak Properties, Inc., the average price target is $18.00, with a high forecast of $21.00, and a low forecast of $17.00.
Highest Price Target
$21.00
Average Price Target
$18.00
Lowest Price Target
$17.00

DOC SharesGrow Score Overview

57/100
SharesGrow Score
Above average fundamentals
View full scorecard →
VALUE 42/100
Valuation — P/E, PEG, Forward PEG
GROWTH 100/100
Financials — average growth
PAST 100/100
strong — trend
HEALTH 33/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 44/100
Gross margin is + market cap
FUTURE 52/100
Analyst outlook — as buy
INCOME 30/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — DOC

~
VALUE Partial
42/100
DOC trades at a trailing Price-to-Earnings (P/E) of 161 (S&P 500 average ~25). Forward PEG 8.11 — overvalued. Trailing PEG 0.6. Analyst consensus target is $18, implying +6.7% from the current price $17. Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
GROWTH Pass
100/100
DOC: +114.2%/yr revenue is, +206.1%/yr Net income is average growth. > 5%/yr — strong. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
PAST Pass
100/100
DOC: 4 / 4 years profitable. strong — 100%. Score = 4 / 4 × 100. ≥ 80 = Pass.
View details →
HEALTH Fail
33/100
Balance sheet DOC: Debt-to-Equity (D/E) ratio 1.39 (moderate), Current ratio is 1.09 (adequate). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
MOAT Fail
44/100
DOC: Gross margin is 22.5% (-45 pp trend), $12B market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 44/100. ≥ 70 = Pass.
View details →
~
FUTURE Partial
52/100
Analyst outlook: 22 / 40 analysts rate DOC as buy (55%). Analyst consensus target is $18 (+6.7% upside). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.
View details →
INCOME Fail
30/100
DOC: Net profit margin is 2.5%. thin (0-5%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range15.71-19.68
Volume5.8M
Avg Volume (30D)9.12M
Market Cap$11.73B
Beta (1Y)1.08
Dividend Yield$1.2200
Share Statistics
EPS (TTM)0.10
Shares Outstanding$696.03M
IPO Date1985-05-23
Employees387
CEOScott Brinker
Financial Highlights & Ratios
Revenue (TTM)$2.82B
Gross Profit$634.55M
EBITDA$1.6B
Net Income$71.35M
Operating Income$544.13M
Total Cash$537.7M
Total Debt$10.44B
Net Debt$9.9B
Total Assets$20.34B
Price / Earnings (P/E)168.7
Price / Sales (P/S)4.16
Analyst Forecast
1Y Price Target$17.00
Target High$21.00
Target Low$17.00
Upside+0.8%
Rating ConsensusBuy
Analysts Covering40
Buy 55% Hold 45% Sell 0%
Price Target Summary
Company Info
CountryUS
ExchangeNYSE
CurrencyUSD
ISINUS42250P1030

Price Chart

DOC
Healthpeak Properties, Inc.  ·  NYSE
Real Estate • REIT - Healthcare Facilities
15.71 52WK RANGE 19.68
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message